Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: A systematic review
Open Access
- 25 January 2024
- journal article
- review article
- Published by Wiley in Health Science Reports
- Vol. 7 (1) , e1844
Abstract
Background and Aims: Pharmacists have been recognized as one of the most qualified healthcare professionals in the clinical implementation of pharmacogenomics, yet its widespread implementation in clinical pharmacy practice has remained limited. The review aims to systematically investigate knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students to inform the future delivery of pharmacogenomics education programs.Methods: PubMed, MEDLINE, Embase, Scopus, and the International Pharmaceutical Abstracts were searched up to May 17, 2022. Studies were selected if they included data on pharmacists' or pharmacy students' knowledge, perception, or attitude about pharmacogenomics and were published in a peer‐reviewed, English‐language journal with full‐text availability. Any published study not deemed original research was excluded. All included studies were critically appraised using the Center for Evidence‐Based Management's critical appraisal tools. The data were descriptively analyzed and presented based on pharmacists' and pharmacy students' knowledge/awareness, perception/attitudes toward pharmacogenomic (PGx), confidence in using or interpreting PGx testing results, and their desire to get further PGx education or their most preferred method of further education.Results: A combined total of 12,430 pharmacists and pharmacy students from 26 countries are represented in the 52 included studies. Despite overwhelmingly positive attitudes and perceptions toward pharmacogenomics among pharmacists and pharmacy students, an overall lack of adequate knowledge and confidence was found. The review also found a strong desire for further pharmacogenomics education among pharmacists and pharmacy students.Conclusion: Pharmacists and pharmacy students have positive perceptions and attitudes toward pharmacogenomics, which is hindered by a lack of knowledge and confidence. However, inadequate control for confounders, limited representativeness of the studied population or region, and small sample sizes diminish the generalizability of the review results. Knowledge and confidence could be improved through enhanced delivery of pharmacogenomic courses within the pharmacy curriculum and continuing education programs.Keywords
This publication has 83 references indexed in Scilit:
- Community Pharmacists‘ Attitudes Towards Clinical Utility and Ethical Implications of Pharmacogenetic TestingPersonalized Medicine, 2013
- Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South AustraliaThe Pharmacogenomics Journal, 2013
- An Evaluation of Pharmacists‘ Expectations Towards PharmacogenomicsPharmacogenomics, 2013
- Knowledge, Attitudes and Education of Pharmacists Regarding Pharmacogenetic TestingPersonalized Medicine, 2011
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011
- Pharmacogenomics in advanced pharmacy practice experiencesCurrents in Pharmacy Teaching and Learning, 2010
- The Canadian Pharmacogenomics Network for Drug Safety: A Model for Safety PharmacologyThyroid®, 2010
- Pharmacogenomics — Drug Disposition, Drug Targets, and Side EffectsNew England Journal of Medicine, 2003
- Hypothesis: Comparisons of inter- and intra-individual variations can substitute for twin studies in drug researchPharmacogenetics, 1998
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998